Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban for Radial Artery Occlusion
NCT06812455Phase 4Recruiting
- Sponsor
- AHEPA University Hospital
- Start
- Mar 2025
- Primary completion
- Mar 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of rivaroxaban in Radial artery occlusion (RAO) (2 arms), sponsored by AHEPA University Hospital. Primary endpoint: Radial artery patency at 4 weeks. Started Mar 2025; status: recruiting.
02
Drugs
rivaroxaban
03
Conditions
Radial artery occlusion (RAO)
Beyond the preview
Go deeper on NCT06812455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06812455.